Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Chronic Spontaneous Urticaria: The Devil's Itch.

Saini SS, Kaplan AP.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1097-1106. doi: 10.1016/j.jaip.2018.04.013. Review.

PMID:
30033911
2.

Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.

Kaplan AP.

Allergy Asthma Proc. 2018 May 1;39(3):184-190. doi: 10.2500/aap.2018.39.4121. Review.

PMID:
29669665
3.

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, Bernstein JA, Bindslev-Jensen C, Brzoza Z, Buense Bedrikow R, Canonica GW, Church MK, Craig T, Danilycheva IV, Dressler C, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Katelaris CH, Kocatürk E, Kulthanan K, Larenas-Linnemann D, Leslie TA, Magerl M, Mathelier-Fusade P, Meshkova RY, Metz M, Nast A, Nettis E, Oude-Elberink H, Rosumeck S, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Staubach P, Sussman G, Toubi E, Vena GA, Vestergaard C, Wedi B, Werner RN, Zhao Z, Maurer M; Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO.

Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397.

PMID:
29336054
4.

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria.

Maurer M, Kaplan A, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Casale TB.

J Allergy Clin Immunol. 2018 Mar;141(3):1138-1139.e7. doi: 10.1016/j.jaci.2017.10.018. Epub 2017 Nov 10. No abstract available.

PMID:
29132956
5.

Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.

Casale TB, Win PH, Bernstein JA, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Antonova EN, Murphy T, Scarupa MD, Sofen H, Kaplan A.

J Am Acad Dermatol. 2018 Apr;78(4):793-795. doi: 10.1016/j.jaad.2017.10.010. Epub 2017 Oct 14. No abstract available.

6.

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.

Kaplan AP.

Allergy Asthma Immunol Res. 2017 Nov;9(6):477-482. doi: 10.4168/aair.2017.9.6.477. Review.

7.

Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.

Finlay AY, Kaplan AP, Beck LA, Antonova EN, Balp MM, Zazzali J, Khalil S, Maurer M.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1715-1721. doi: 10.1111/jdv.14384. Epub 2017 Jul 19.

8.

Why a registry of Chronic Urticaria (CUR) is needed.

Gómez RM, Jares E, Canonica GW, Baiardini I, Passalacqua G, Sánchez Borges M, Kaplan AP, Baena-Cagnani CE.

World Allergy Organ J. 2017 May 16;10(1):16. doi: 10.1186/s40413-017-0147-2. eCollection 2017.

9.

Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria.

Zazzali JL, Kaplan A, Maurer M, Raimundo K, Trzaskoma B, Antonova EN, Rosén KE.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):524. doi: 10.1016/j.anai.2016.12.023. No abstract available.

PMID:
28390589
10.

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Kaplan AP, Giménez-Arnau AM, Saini SS.

Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4. Review.

11.

Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.

Zazzali JL, Kaplan A, Maurer M, Raimundo K, Trzaskoma B, Solari PG, Antonova E, Mendelson M, Rosén KE.

Ann Allergy Asthma Immunol. 2016 Oct;117(4):370-377.e1. doi: 10.1016/j.anai.2016.06.024. Epub 2016 Jul 14.

12.

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.

Kaplan A, Ferrer M, Bernstein JA, Antonova E, Trzaskoma B, Raimundo K, Rosén K, Omachi TA, Khalil S, Zazzali JL.

J Allergy Clin Immunol. 2016 Feb;137(2):474-81. doi: 10.1016/j.jaci.2015.08.023. Epub 2015 Oct 21.

13.

How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria.

Kaplan AP, Joseph K, Saini SS.

J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):648. doi: 10.1016/j.jaip.2015.04.008. No abstract available.

PMID:
26164583
14.

Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.

Casale TB, Bernstein JA, Maurer M, Saini SS, Trzaskoma B, Chen H, Grattan CE, Gimenéz-Arnau A, Kaplan AP, Rosén K.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):743-50.e1. doi: 10.1016/j.jaip.2015.04.015. Epub 2015 Jun 6.

15.

Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'.

Rosén K, Maurer M, Hsieh H, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T.

Br J Dermatol. 2014 Jul;171(1):15-6. doi: 10.1111/bjd.13075. No abstract available.

PMID:
25066290
16.

Biologic agents and the therapy of chronic spontaneous urticaria.

Kaplan AP, Popov TA.

Curr Opin Allergy Clin Immunol. 2014 Aug;14(4):347-53. doi: 10.1097/ACI.0000000000000083. Review.

PMID:
24936849
17.

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M; European Academy of Allergy and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization.

Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30.

PMID:
24785199
18.

The maddening itch: an approach to chronic urticaria.

Viegas LP, Ferreira MB, Kaplan AP.

J Investig Allergol Clin Immunol. 2014;24(1):1-5. Review.

19.

Therapy of chronic urticaria: a simple, modern approach.

Kaplan AP.

Ann Allergy Asthma Immunol. 2014 May;112(5):419-25. doi: 10.1016/j.anai.2014.02.014. Epub 2014 Mar 20. Review.

PMID:
24656924
20.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.

Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, Veith J, Kamath N, Staubach P, Jakob T, Stirling RG, Kuna P, Berger W, Maurer M, Rosén K.

J Allergy Clin Immunol. 2013 Jul;132(1):101-9. doi: 10.1016/j.jaci.2013.05.013.

PMID:
23810097

Supplemental Content

Loading ...
Support Center